New Clinical Trial Explores Inspiratory Muscle Training for Cognitive and Cerebral Benefits in Sleep Apnea Patients

A pioneering clinical trial, sponsored by Istinye University, is set to investigate the potential impacts of inspiratory muscle training (IMT) on cognitive functions, cerebral oxygenation, and neurotrophic factor levels in patients diagnosed with Obstructive Sleep Apnea Syndrome (OSAS). This announcement is particularly relevant for clinical regulation teams and healthcare professionals focused on non-invasive interventions for chronic conditions. The study is not yet recruiting as of January 2026.

In this article:

What changed?

The study titled “The Effect of Inspiratory Muscle Training on Cognitive Functions, Cerebral Oxygenation, and Neurotrophic Factor Level in Patients With Obstructive Sleep Apnea Syndrome” marks a significant step forward in addressing OSAS with innovative approaches. The addition of IMT devices to usual care provides a non-invasive option under clinical evaluation. This trial aims to rigorously measure improvements in both physical and cognitive health.

Key details of the trial

What is the study aiming to evaluate?

Obstructive Sleep Apnea Syndrome affects a significant portion of the adult population and is known to impair cognitive performance and reduce cerebral oxygenation. This study will assess how IMT improves these critical dimensions. Researchers will use three types of intervention:

  • Device-Based IMT: Patients will use specialized inspiratory muscle training devices designed to enhance breathing strength and efficiency.
  • Placebo IMT: A sham IMT device will serve as the control to validate the therapeutic efficacy.
  • Usual Care: The baseline standard of care for OSAS patients.

Who is supporting this initiative?

Istinye University is sponsoring the trial to bridge gaps in understanding the systemic effects of breathing exercises on brain health. Their research could pave the way for a potential shift in OSAS management.

What is the current status of the study?

As of January 2026, the study has not started its recruitment phase. Healthcare professionals and eligible participants are advised to monitor the trial’s ClinicalTrials.gov page for updates.

Potential implications for patients and stakeholders

This study could redefine treatment protocols for OSAS by demonstrating the broader benefits of IMT on neurocognitive and physiological health. Positive findings may influence regulatory guidelines, making non-invasive respiratory care a preferred intervention.

The outcomes may also attract interest from medical device manufacturers and clinical teams exploring better management strategies for OSAS. Should the results validate the hypothesis, IMT devices could gain greater prominence in treatment recommendations.

Frequently Asked Questions

  1. What is inspiratory muscle training (IMT)?
    IMT is a breathing technique that strengthens the muscles involved in respiration using a device that adds resistance to inhalation.
  2. Who can participate in the study?
    Eligibility details will be updated on the ClinicalTrials.gov study page once recruitment begins.
  3. What is the significance of neurotrophic factor levels?
    Neurotrophic factors regulate brain health, including nerve development and cognitive function. Measuring these levels could reveal new dimensions of therapy efficacy.

Conclusion

As obstructive sleep apnea continues to challenge the healthcare landscape, studies like this aim to uncover novel, non-invasive interventions. This trial’s findings could influence clinical practices and regulatory policies. Stakeholders are encouraged to monitor updates and consider implications for device development and healthcare delivery.

Disclaimer

This article is for informational purposes only and does not constitute legal or clinical advice. Always consult official sources for regulatory guidance or medical recommendations.

For full information about the announcement, see the link below.

https://clinicaltrials.gov/study/NCT07329049?term=medical+device

Scroll to Top